Status:
UNKNOWN
ACP in Older Patients With Multimorbidity: a Randomized Pilot
Lead Sponsor:
Erasmus Medical Center
Conditions:
Advance Care Planning
Multimorbidity
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Rationale A recent study into the patient perspective of patients with multiple chronic conditions in the Netherlands underlines the strain multimorbidity can put on people. Most patients would apprec...
Detailed Description
A recent study into the patient perspective of patients with multiple chronic conditions in the Netherlands underlines the strain multimorbidity can put on people. Conducting semi-structured, in-depth...
Eligibility Criteria
Inclusion
- Polypharmacy (i.e. use of ≥ 5 medications for longer than six months)
- ≥ 2 hospitalizations, day clinic admissions and/or individual ER admissions in the last 12 months
- Charlson Comorbidity Index (CCI) of ≥ 5 (unadjusted for age)
- Written informed consent to participate
Exclusion
- Unable to complete questionnaire or interview in Dutch
- Less than 6 months anticipated life expectancy
- Serious cognitive impairment (MMSE score \< 16)
Key Trial Info
Start Date :
May 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04856202
Start Date
May 15 2021
End Date
April 30 2023
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC
Rotterdam, North Holland, Netherlands, 3000CA